Comment
doi: 10.1001/jamanetworkopen.2021.36510.
Do the Selective Serotonin Reuptake Inhibitor Antidepressants Fluoxetine and Fluvoxamine Reduce Mortality Among Patients With COVID-19?
Affiliations
- PMID: 34779851
- DOI: 10.1001/jamanetworkopen.2021.36510
Item in Clipboard
Comment
Do the Selective Serotonin Reuptake Inhibitor Antidepressants Fluoxetine and Fluvoxamine Reduce Mortality Among Patients With COVID-19?
JAMA Netw Open.
.
Free article
No abstract available
Comment on
-
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.JAMA Netw Open. 2021 Nov 1;4(11):e2133090. doi: 10.1001/jamanetworkopen.2021.33090. JAMA Netw Open. 2021. PMID: 34779847 Free PMC article.
Similar articles
-
The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis.PLoS One. 2022 Oct 6;17(10):e0267423. doi: 10.1371/journal.pone.0267423. eCollection 2022. PLoS One. 2022. PMID: 36201406 Free PMC article.
-
Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19.Int J Mol Sci. 2022 Mar 30;23(7):3812. doi: 10.3390/ijms23073812. Int J Mol Sci. 2022. PMID: 35409171 Free PMC article. Review.
-
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use.Eur J Clin Pharmacol. 2022 Oct;78(10):1601-1611. doi: 10.1007/s00228-022-03372-5. Epub 2022 Aug 9. Eur J Clin Pharmacol. 2022. PMID: 35943535 Free PMC article. Review.
-
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review.J Clin Psychopharmacol. 2022 May-Jun 01;42(3):284-292. doi: 10.1097/JCP.0000000000001543. Epub 2022 Apr 14. J Clin Psychopharmacol. 2022. PMID: 35420565 Free PMC article.
-
Fluvoxamine for COVID-19?Med Lett Drugs Ther. 2021 May 3;63(1623):69-70. Med Lett Drugs Ther. 2021. PMID: 33976099 No abstract available.
Cited by
-
Effects of Antidepressants on COVID-19 Outcomes: Retrospective Study on Large-Scale Electronic Health Record Data.Interact J Med Res. 2023 Apr 11;12:e39455. doi: 10.2196/39455. Interact J Med Res. 2023. PMID: 36881541 Free PMC article.
-
Fluvoxamine for the Early Treatment of COVID-19: A Meta-analysis of Randomized Clinical Trials.Am J Trop Med Hyg. 2022 Mar 9;106(5):1315-20. doi: 10.4269/ajtmh.21-1310. Online ahead of print. Am J Trop Med Hyg. 2022. PMID: 35263710 Free PMC article.
-
The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID-19 patients: A systematic review and meta-analysis.Health Sci Rep. 2022 Oct 17;5(6):e892. doi: 10.1002/hsr2.892. eCollection 2022 Nov. Health Sci Rep. 2022. PMID: 36268458 Free PMC article.
-
Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution.Front Psychiatry. 2022 Oct 19;13:1052710. doi: 10.3389/fpsyt.2022.1052710. eCollection 2022. Front Psychiatry. 2022. PMID: 36339865 Free PMC article. No abstract available.
-
Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study.Mol Psychiatry. 2023 Dec;28(12):5411-5418. doi: 10.1038/s41380-023-02004-3. Epub 2023 Mar 3. Mol Psychiatry. 2023. PMID: 36869228 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
